SOPHiA GENETICS welcomes you at our booth at ESMO2024!
We are excited to invite you to join us at ESMO 2024!
Find out how we advance data-driven medicine, with our cloud-based SOPHiA DDM™ Platform. Discover how it empowers health data interpretation with advanced analytics modules, simplified reporting, and a global community of healthcare institutions.
By harnessing the power of AI and multimodal data-driven analytics, we enable you to advance and streamline global access to precision therapies.
Posters: September 13th, 08:30 to 10:00 AM
Analytical Validation of an NGS Panel-Based ecDNA Detection Device for Use as a Clinical Trial Assay for BBI-335 Clinical Study
Presented by Julien Pontis
Technical Product Manager and Lead Data Scientist at SOPHiA GENETICS
TRIDENT: Machine learning (ML) multimodal signatures to identify patients that would benefit most from tremelimumab (T) addition to durvalumab (D) + chemotherapy (CT) with data from the POSEIDON trial